Clinical values of detecting excision repair cross complementing 1 and top-oisomerase I in individualized therapies of metastatic colorectal cancer
Clinical values of detecting excision repair cross complementing 1 and top-oisomerase I in individualized therapies of metastatic colorectal cancer
摘要
Objective To explore the clinical values of detecting drug related molecules excision repair cross complementing 1(ERCC1)and top-oisomeraseⅠ(TOPOⅠ)in individualized therapies of metastatic colorectal cancer.Methods From June 2009 to December 2011,90 patients at Huadong Hospital with metastatic colorectal cancer were
-
1李剑英,王建红,许春明,杨磊,季从飞,谭清和.西妥昔单抗联合FOLFIRI方案一线治疗转移性结直肠癌的疗效观察[J].临床与病理杂志,2014,34(4):420-424. 被引量：3
-
2张晓瑞.西妥昔单抗联合化疗治疗转移性结直肠癌疗效观察[J].山西职工医学院学报,2016,26(5):30-32. 被引量：1
-
3李慧明,余英豪.转移性结直肠癌靶向治疗中的关键分子[J].世界华人消化杂志,2014,22(3):350-358. 被引量：6
-
4曲颜丽,赛福丁·克尤木,唐勇.贝伐珠单抗联合化疗治疗转移性结直肠癌的疗效和安全性[J].世界华人消化杂志,2016,24(17):2748-2754. 被引量：2
-
5陈青青,范惠珍.Tiam 1与转移性结直肠癌的研究进展[J].宜春学院学报,2016,38(9):17-20.
-
6于鹏,马进元,朱步东.转移性结直肠癌全身治疗原则、现状和进展[J].中华临床医师杂志（电子版）,2013,7(9):168-169. 被引量：3
-
7高广辉,周鑫莉,黄若凡,蒋京伟,初钊辉,梁晓华.西妥昔单抗治疗转移性结直肠癌的荟萃分析[J].肿瘤,2009,29(3):253-258. 被引量：7
-
8尹良伟,王苏平,张利,王颖,纪军,王贺双,郭旭,王晓虹,马舒贝,杜晓红,马海英.DC-CIK过继性免疫疗法联合化疗治疗转移性结直肠癌患者的疗效[J].中国肿瘤生物治疗杂志,2013,20(2):217-224. 被引量：21
-
9Janja Ocvirk,Thomas Brodowicz,Fritz Wrba,Tudor E Ciuleanu,Galina Kurteva,Semir Beslija,Ivan Koza,Zsuzsanna Pápai,Diethelm Messinger,Ugur Yilmaz,Zsolt Faluhelyi,Suayib Yalcin,Demetris Papamichael,Miklós Wenczl,Zrinka Mrsic-Krmpotic,Einat Shacham-Shmueli,Damir Vrbanec,Regina Esser,Werner Scheithauer,Christoph C Zie-linski.Cetuximab plus FOLFOX6 or FOLFIRI in metastatic colorectal cancer: CECOG trial[J].World Journal of Gastroenterology,2010,16(25):3133-3143. 被引量：17
-
10杜立法,王俊杰.大肠癌靶向治疗现状[J].癌症进展,2012,10(6):569-575.
